Jesper Brandgaard

Jesper Brandgaard holds an MSc in Economics and Auditing, as well as an MBA, both from the Copenhagen Business School, Denmark. He joined Novo Nordisk A/S in 1999 as Senior Vice President of Corporate Finance and was appointed CFO in 2000. He left Novo Nordisk in 2019 to pursue a non-executive career. He is member of several boards, including Vice Chair of Chr. Hansen Holding, Vice Chair of William Demant Invest, member of the board of William Demant Foundation, member of the Danish Corporate Governance Committee (Komitéen for god Selskabsledelse) and member of the advisory board of Vækstpartner Kapital.

Positions and management duties

• Chair: Leo Pharma A/S (Chair of the Remuneration and Nomination, and IPO Preparedness Committees), DK.
• Vice Chair: William Demant Invest A/S, DK.
• Member: William Demant Fonden and the Advisory Board of the private equity company, VaekstPartner Kapital, both DK.
• Director of JBR Counselling ApS and member of the Danish Committee on Corporate Governance, both DK.

Education

• Mr. Brandgaard holds an MSc in Economics and Auditing, as well as an MBA, both from the Copenhagen Business School, Denmark.